Contact us:
973-983-7429
support@4hcm.org

66 Ford Road - Suite 213B
Denville, NJ 07834
Elena Morgan • May 13, 2024
HCMA’s Lifesaving Engagement in the Local Community 

On April 20th, HCMA spread awareness of HCM and sudden cardiac arrest (SCA) at the Denville Little League’s opening day ceremony, which attracted over 1,000 residents. At HCMA’s booth, Lisa Salberg, Elena Morgan, Adam Salberg, Lisa Vecchione, Kim Walsh, Arniella Santos, and John Titus, shared information about HCM and SCA preparedness, while promoting an upcoming training focused on sports teams– Drill: Dr. Heart

On April 27th, HCMA led a Drill: Dr. Heart training session. This hands-on training was designed to equip attendees with the skills to respond effectively to cardiac emergencies. One of the highlights of the training was the introduction to the new Automated External Defibrillators (AEDs) at Denville sports fields, led by Denville Emergency Manager, Wesley Sharples.  The training wasn’t just for sports enthusiasts; it was emphasized that these skills are invaluable in various settings including workplaces, schools, and social gatherings—anywhere hearts gather.

The goal of Drill: Dr. Heart is to ensure that every sports team, student activity, classroom, and workplace is prepared for sudden cardiac arrest. Thanks to support from Defibtech, HCMA will give away four AEDs to deserving schools, sports teams, houses of worship, or community organizations through the Drill: Dr. Heart initiative. If you’d like to win an AED for your organization, complete the drill with your group and then complete this form to enter our competition. 

HCMA Blog

March 24, 2025
Who should have genetic testing, and when?
A photo-realistic image of  heart, lit from behind, on a black background.
March 11, 2025
Health educator Sabrina Cuddy discusses common arrhythmias in HCM, like atrial flutter/fibrillation, ventricular tachycardia/fibrillation, left or right bundle branch block, PVC, PAC, and others. Some arrhythmias are harmless, while others are serious and need treatment.
Chart representing mavacamten trial results with total patients, and results in blue bar format.
By Gordon Fox March 10, 2025
Camzyos provided significant reduction of obstruction. Initially all patients were obstructed (that is, they had gradients of at least 30mmHg after valsalva maneuvers). After 3 months on Camzyos, about 57% were no longer obstructed. After 6 months, about 70% had no obstruction.
More Posts
Share by: